TON - September/October 2014 Vol 7 No 5

Cancer and its treatments affect sexuality, but this is not typically discussed with patients. Patients with cancer are often not forthcoming about sexuality, and nurses and other healthcare practitioners may not be comfortable raising the issue. Read More ›

aginal dehydroepiandrosterone (DHEA) may improve sexual function, without negative systemic effects, in women with breast and gynecologic cancer with vaginal and sexual-related complaints. Read More ›

Imagine you’ve been feeling more tired lately, but you think, who isn’t? You work long hours at the office and at home. The fatigue becomes worse. After a battery of blood tests, the practitioner tells you the results. Read More ›

In breast cancer patients with bone metastasis, less frequent infusion of zoledronic acid was as effective as the standard monthly dose, the randomized OPTIMIZE-2 study showed. Read More ›

Recently, the American College of Physicians (ACP) released a statement on its website with the headline “American College of Physicians recommends against screening pelvic examination in adult, asymptomatic, average risk, non-pregnant women.” Read More ›